Phase I study of oral GZ17-6.02 in patients with advanced solid tumors or lymphoma

被引：0
|
作者：
Mita, A. [1 ]
Mita, M. [1 ]
Tsai, F. [2 ]
Moore, R. P. [3 ]
Bailes, J. [3 ]
Matrana, M. [4 ]
机构：
[1] Cedars Sinai Med Ctr, Oncol, Los Angeles, CA 90048 USA
[2] Honor Hlth Res & Innovat Inst, Oncol, Scottsdale, AZ USA
[3] Genzada Pharmaceut, R&D, Hutchinson, KS USA
[4] Ochsner Canc Inst, Oncol, New Orleans, LA USA
来源：
ANNALS OF ONCOLOGY | 2021年 / 32卷
关键词：
D O I：
10.1016/j.annonc.2021.08.1070
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
548P
引用
收藏
页码：S609 / S610
页数：2
相关论文
共 50 条
  • [31] A phase I study of the ceramide nanoliposome in patients with advanced solid tumors
    Aaron Ciner
    Theodore Gourdin
    Jeff Davidson
    Mylisa Parette
    Susan J. Walker
    Todd E. Fox
    Yixing Jiang
    Cancer Chemotherapy and Pharmacology, 2024, 93 : 23 - 29
  • [32] A phase i study of ixazomib and erlotinib in patients with advanced solid tumors
    Shumei Kato
    Jacob J. Adashek
    Vivek Subbiah
    Siqing Fu
    Mianen Sun
    Ly Nguyen
    Elsa J. Brown
    Timothy A. Yap
    Daniel D. Karp
    Sarina A. Piha-Paul
    David S. Hong
    Investigational New Drugs, 2022, 40 : 99 - 105
  • [33] Phase I study of piritrexim and gemcitabine in patients with advanced solid tumors
    Huie, M
    Carducci, M
    Liu, G
    Wilding, GG
    Marnocha, R
    Izquierda, M
    Thomas, J
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2005, 28 (06): : 613 - 617
  • [34] Phase I study on docetaxel and Gemcitabine in patients with advanced solid tumors
    Jaremtchuk, AV
    Zarba, JJ
    Ferro, A
    ANNALS OF ONCOLOGY, 1998, 9 : 138 - 139
  • [35] A phase I study of bortezomib and temozolomide in patients with advanced solid tumors
    J. Portnow
    P. Frankel
    S. Koehler
    P. Twardowski
    S. Shibata
    C. Martel
    R. Morgan
    M. Cristea
    W. Chow
    D. Lim
    V. Chung
    K. Reckamp
    L. Leong
    T. W. Synold
    Cancer Chemotherapy and Pharmacology, 2012, 69 : 505 - 514
  • [36] A phase I study of resminostat in Japanese patients with advanced solid tumors
    Kitazono, Satoru
    Fujiwara, Yutaka
    Nakamichi, Shinji
    Mizugaki, Hidenori
    Nokihara, Hiroshi
    Yamamoto, Noboru
    Yamada, Yasuhide
    Inukai, Eri
    Nakamura, Osamu
    Tamura, Tomohide
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2015, 75 (06) : 1155 - 1161
  • [37] A phase 1 study of oral ridaforolimus in pediatric patients with advanced solid tumors
    Pearson, Andrew D. J.
    Federico, Sara M.
    Aerts, Isabelle
    Hargrave, Darren R.
    DuBois, Steven G.
    Iannone, Robert
    Geschwindt, Ryan D.
    Wang, Ruixue
    Haluska, Frank G.
    Trippett, Tanya M.
    Geoerger, Birgit
    ONCOTARGET, 2016, 7 (51): : 84736 - 84747
  • [38] A phase 1 study of oral navelbine in patients with advanced solid tumors.
    Rajdev, L
    Dai, Q
    Mani, S
    Goldberg, G
    Baker, C
    Hoschander, S
    Sparano, J
    CLINICAL CANCER RESEARCH, 2003, 9 (16) : 6137S - 6137S
  • [39] Phase I study of oral gemcitabine prodrug (LY2334737) in Japanese patients with advanced solid tumors
    Yamamoto, Noboru
    Nokihara, Hiroshi
    Yamada, Yasuhide
    Uenaka, Kazunori
    Sekiguchi, Risa
    Makiuchi, Takeshi
    Slapak, Christopher A.
    Benhadji, Karim A.
    Tamura, Tomohide
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2013, 71 (06) : 1645 - 1655
  • [40] A phase I dose-escalation and pk study of continuous oral rucaparib in patients with advanced solid tumors
    Flynn, M.
    Shapiro, G.
    LoRusso, P.
    Kristeleit, R.
    Patel, M.
    Infante, J.
    Giordano, H.
    Borrow, J.
    Jaw-Tsai, S.
    Burris, H., III
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S185 - S185
12345